Pre-eclampsia surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
== Delivery == | == Delivery == | ||
[[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following: | [[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following: | ||
:*Repeated episodes of severe hypertension despite maintenance treatment with 3 classes of antihypertensive agents | :*Repeated episodes of [[severe hypertension]] despite maintenance treatment with 3 classes of antihypertensive agents | ||
:*Progressive [[thrombocytopenia]] | :*Progressive [[thrombocytopenia]] | ||
:*Progressively abnormal [[renal]] or [[liver]] enzyme tests | :*Progressively abnormal [[renal]] or [[liver]] enzyme tests | ||
Revision as of 12:09, 8 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia surgery On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Delivery
Delivery is the mainstay of therapy for preeclampsia in the 37 weeks of gestation or occurrence any of the following:
- Repeated episodes of severe hypertension despite maintenance treatment with 3 classes of antihypertensive agents
- Progressive thrombocytopenia
- Progressively abnormal renal or liver enzyme tests
- Pulmonary edema
- Abnormal neurological features, such as severe intractableheadache, repeated visual scotomata,convulsions
- Nonreassuring fetal status